USPTO serial 99520613
GOSIA GENOMICS
Status 641Office Action
- Filing date
- Nov 28, 2025
- Status date
- Apr 13, 2026
- Registration date
- —
- Examiner
- GOLDEN, LAURA DAWN
Need help with GOSIA GENOMICS?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Owner
Gosia Genomics Inc
Kearny, NJ, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Online retail store services featuring DNA collection kits and health and wellness analysis services | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring non-downloadable software using artificial intelligence (AI) specifically focused on women's health, general health and wellness, diagnosis, and predisposition risk assessment, which includes the analysis, interpretation, reporting, knowledge portal, patient monitoring, and personalized recommendations based on genomic data, and may include other laboratory test results; Scientific research in the fields of women's health, general wellness, genomics, and artificial intelligence (AI) | ACTIVE | — |
| 044 | (Based on Use) Genomic testing and analyses services for wellness, diagnostic, and predisposition testing specifically focused on women's health, including gynecological and menstrual health, reproductive health, fertility, menopause, maternal and pregnancy health, skin care, diet, sleep, and fitness; General genomic testing and analyses services for wellness, diagnostic, longevity, and predisposition testing for gut health, nutrition, diet, weight loss, food intolerance, fitness, skin care, dermatology, medical aesthetics, pharmacogenomics, and cognitive health; (Based on Intent to Use) Health coaching and nutrition counseling services for general health and lifestyle wellness, with a specific focus on women's health, including gynecological, menstrual, reproductive, peri-menopause, menopause, post-menopause, maternal, and pregnancy health; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, including hormone level testing services | ACTIVE | Jul 27, 2025 |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Jul 12, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Jul 12, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Apr 13, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 13, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Apr 13, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Apr 1, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Mar 26, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 28, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Nov 28, 2025 | NWAP | NEW APPLICATION ENTERED |